India’s largest vaccine manufacturer, Serum Institute of India (SII) CEO Adar Poonawalla on Saturday shared good news for the travelers over the Covishield vaccine acceptance.
As France accepts Covishield, the Indian version of Oxford-Astrazeneca vaccine, CEO Poonawalla took to his micro-blogging site to share the good news for travelers concerned to visit the European nations as the 16 nations have now recognized Covishield for entry of international travelers.
“It is indeed good news for travelers, as we see sixteen
European countries recognizing COVISHIELD as an acceptable vaccine for entry.
However despite being vaccinated, entry guidelines might vary from country to
country, so do read up before you travel,” Poonawalla wrote.
It is to be reiterated here, the Indian govt has been
pushing up European Union member countries to recognize both Covishield and
Covaxin. The GoI has even made it clear that if the nations won’t agree then travelers from those countries, who had received jab of EU-recognised
vaccines, will not be exempt from quarantine in India.
Also Read:Revised price of Covishield and Covaxin, Rs 215 and 225 respectively
So finally here are the 16 countries including Austria, Belgium, Bulgaria, Finland, Germany, Greece, Hungary, Iceland, Ireland, Latvia, the Netherlands, Slovenia, Spain, Sweden, Switzerland, and France that recognized Covishield vaccine for international travelers. Pertinently, of these countries, 13 are European Union members.
Notably, this recognition paves the way for the Indians, who had taken Covishield jab, to travel to these European countries, once they gradually lift their travel restrictions. However, some countries may also require negative RT/PCR test reports as the entry requirement will vary from country to country.